Conquer Drug Pricing Challenges
Make confident decisions with the help of trusted drug pricing concepts and attributes from Medi-Span
Stay on top of market trends and remain competitive with Medi-Span pricing data
Enhance your market knowledge to assist with pricing and positioning decisions using Medi-Span drug pricing benchmark data points.
To help you make timely and confident decisions, Medi-Span regularly provides new and updated pricing information enabled by our long-standing relationships with pharmaceutical manufacturers.
You can also be confident that our pricing benchmark information will always remain as unbiased as possible, as it published independently under Medi-Span proprietary editorial policies.
The benchmarks you need – from AWP to WAC – from a source you can trust
Medi-Span pricing data provides you with a wide variety of pricing concepts, including Average Wholesale Price (AWP) and Wholesale Acquisition Cost (WAC), as well as key reimbursement attributes, so you can more confidently make decisions.
-
Average Wholesale Acquisition Cost Pricing (AWAC)Support your pricing analytics with Medi-Span AWAC which provides both AWAC and Generic Equivalent WAC (GEWAC) pricing with current and up to 12 historical prices. We help you by providing a way to determine WAC pricing for a specific NDC when it is unavailable from the manufacturer. You will also receive information necessary to build a WAC-based Price Index for reimbursement rules or payment rules for multiple-source pharmaceutical products.
-
Federal Government Pricing
- Establish and compare pricing methodologies for state Medicaid and beyond.
- Saves you time by eliminating manual processing of pricing updates and data output changes from the government, and by delivering NADAC and/or ACA FUL pricing data in one resource
- Helps you stay current with content updates as often as daily when Centers for Medicare and Medicaid Services (CMS) posts new data
- Supports a wide range of applications by linking pricing data to National Drug Codes (NDCs)
- Assists payers/PBMs in considering price points when establishing contracts, particularly those involving state Medicaid
- Helps retail pharmacies anticipate baseline pricing for state Medicaid programs
-
Medicare Plans
- Helps save time spent researching and monitoring Medicare reimbursement designations by providing access to Part B and Part D indicators in one consolidated source
- Helps reduce tedious manual updates — the file automatically updates with new NDCs and changes in Medicare status as they become available
-
Medicaid Rebates
Avoid constant monitoring of Medicaid Rebate Programs.
- Helps increase efficiency as you can avoid manual monitoring of the Centers for Medicare and Medicaid Services’ (CMS) website for updates
- Saves you time by providing the same information published by the government as part of your regular drug file delivery while helping you with layout changes and non-routine postings by the government
-
Medi-Span Electronic Drug File (MED-File) v2This foundational drug file provides you with regularly updated codified drug dictionary, drug vocabulary, and drug pricing for prescription drugs and medication-based over-the-counter products in the United States.
-
Payment Allowance Limit – Part B (PAL-B) v2Streamline your medicare reimbursement activities. To support healthcare businesses’ Medicare coverage-related decision-making needs, PAL-B v2 provides consolidated access to timely reimbursement information for drugs covered under Medicare Part B, as published by the Centers for Medicare and Medicaid Services (CMS).
As a claims processor, we rely on Medi-Span and its wealth of drug information to forecast and price claims for our clients. Medi-Span is the go-to (data source) that is recognized across the industry for (manufacturer-provided) drug information. They have innovative tools and excellent customer service that will go above and beyond to provide the best available solution.